Analysis of the characteristics of registered clinical trials of lipid-lowering drugs in China from 2013 to 2025
1.NHC Key Laboratory of Clinical Research for Cardiovascular Medications, National Clinical Research Center of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
2.Vanke School of Public Health, Tsinghua University, Beijing 100084, China
3.National Clinical Research Center for Cardiovascular Diseases, Phase Ⅰ Ward, Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing 100037, China
收起